Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Greg
    Member
    • Oct 2009
    • 31

    Cuffdiff NOTEST for splicing.diff

    Using the tophat/cufflinks combo to find differential alternative splicing.

    The cuffdiff manual says that if there "not enough alignments for testing" then you will get NOTEST and the treatments will not be compared. Does anyone have an idea as to what the cutoff for this is? Many of the genes that get NOTEST in my data set (single end) have a large number of reads (several hundred). Could it be because of insufficient coverage? or maybe operator error?

    thanks!
  • Greg
    Member
    • Oct 2009
    • 31

    #2
    So I just found the -c option to set the number of required reads. It does change the number of tests that happen but there are still less then I would think. Any ideas? What are the other criteria for doing the test or not? Would more info on my workflow be helpful?

    Comment

    • griffon42
      Member
      • Jan 2009
      • 23

      #3
      I'm experiencing the same issue. I'm using cufflinks 0.8.3 (the 7/2 release) and the -c option doesn't seem to work as described in the manual. As extreme examples, I have loci that are "OK" for stat testing and "yes" for significant but have only 2 reads vs. 0 reads across samples.

      As mentioned, changing -c DOES affect the number of loci tested, but not by much and it does not fix situations like that described above.

      Does anyone know how to manage this situation? The differential expression output files i'm generating are rather unmanageable.

      Thanks.

      Comment

      • jetspeeder
        Member
        • Jun 2010
        • 12

        #4
        I have a lot of NOTEST and FAIL as well,

        Also do you guys know the significance of this and why the percentages are high for missed and wrong exons and what the signifies? Thanks.

        #> Genomic sequence: chr1
        # Query mRNAs : 20972 in 20055 loci (3356 multi-exon transcripts)
        # (633 multi-transcript loci, ~1.0 transcripts per locus)
        # Reference mRNAs : 1024 in 912 loci (966 multi-exon)
        # Corresponding super-loci: 695
        #--------------------| Sn | Sp | fSn | fSp
        Base level: 63.4 16.4 - -
        Exon level: 37.6 9.6 44.0 11.3
        Intron level: 52.6 31.5 53.4 31.9
        Intron chain level: 18.6 5.4 24.7 7.1
        Transcript level: 0.0 0.0 0.1 0.0
        Locus level: 19.5 0.9 22.9 1.0
        Missed exons: 2554/8302 ( 30.8%)
        Wrong exons: 26036/32327 ( 80.5%)
        Missed introns: 3161/7289 ( 43.4%)
        Wrong introns: 7825/12186 ( 64.2%)
        Missed loci: 208/912 ( 22.8%)
        Wrong loci: 17823/20055 ( 88.9%)

        Comment

        • Greg
          Member
          • Oct 2009
          • 31

          #5
          I've had the same experience. Could only guess...

          Comment

          • SEQond
            Member
            • Jul 2010
            • 27

            #6
            So anyone has an idea on how to find the ideal -c "minimum number of alignments in a locus for needed to conduct significance testing" (--min-alignment-count) ?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 12:17 PM
            0 responses
            9 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, Yesterday, 11:41 AM
            0 responses
            10 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...